Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
Free plan · Plus CA$29 or Pro CA$99/month


